nontox
nine
residu
peptid
nivnvslvk
shown
interfer
insulin
fibril
variou
biophys
method
insulin
undergo
conform
chang
certain
stress
condit
lead
amyloid
fibril
fibril
insulin
pose
problem
longterm
storag
reduc
efficaci
treat
type
ii
diabet
dissoci
insulin
oligom
monom
key
step
onset
fibril
time
cours
insulin
fibril
use
thioflavin
fluoresc
show
increas
lag
time
min
without
peptid
min
peptid
transmiss
electron
micrograph
show
branch
insulin
fibril
absenc
less
interfibril
associ
presenc
upon
incub
ph
insulin
lost
ahel
structur
seen
fourier
transform
infrar
spectroscopi
ftir
peptid
ad
secondari
structur
almost
fulli
maintain
h
though
lost
partial
h
ftir
spectroscopi
also
show
insulin
form
cross
beta
structur
indic
fibril
beyond
h
presenc
peptid
ahelix
retent
seen
till
h
size
exclus
chromatographi
dynam
light
scatter
show
insulin
primarili
exist
trimer
whose
convers
monom
resist
peptid
satur
transfer
differ
nuclear
magnet
reson
confirm
hydrophob
residu
peptid
close
contact
insulin
hydrophob
groov
molecular
dynam
simul
conjunct
princip
compon
analys
reveal
peptid
interrupt
insulin
fibril
vitro
hemolyt
activ
peptid
show
insignific
cytotox
cell
insulin
aggreg
probe
due
inter
play
two
key
residu
phe
tyr
monitor
molecular
dynam
simul
studi
new
peptid
base
lead
may
develop
nine
residu
peptid
citat
banerje
v
kar
rk
datta
parthasarathi
k
chatterje
et
al
use
small
peptid
fragment
inhibitor
insulin
fibril
process
studi
high
low
resolut
spectroscopi
plo
one
protein
fibril
one
import
physiolog
process
link
develop
mani
patholog
condit
affect
qualiti
life
mankind
alzheim
diseas
prionassoci
encephalopathi
huntington
diseas
type
ii
diabet
parkinson
diseas
mani
diseas
link
protein
fibril
fibril
process
globular
protein
undergo
structur
perturb
follow
seri
structur
transit
lead
format
insolubl
fibril
contain
bcross
sheet
like
structur
excess
depositionaccumul
stabl
order
amorph
protein
aggreg
collect
call
amyloid
fibril
deposit
excess
stabl
order
amorph
protein
aggreg
organ
tissu
lead
crucial
biolog
dysfunct
deleteri
patholog
symptom
research
till
date
explor
fact
despit
divers
sequenc
homolog
protein
fibril
share
similar
format
pathway
similar
morpholog
howev
exact
biochemicalbiophys
pathway
mechan
protein
fibril
yet
fulli
understood
insulin
protein
hormon
central
regul
bloodglucos
level
due
propens
undergo
stress
induc
conform
chang
lead
variou
aggreg
form
includ
amyloid
fibril
becom
subject
intens
studi
model
fibril
form
system
also
insulin
instabl
issu
reduc
efficaci
insulin
therapi
type
ii
diabet
patholog
fingerprint
fibrillar
insulin
report
amyloid
deposit
patient
diabet
normal
age
deposit
take
place
mostli
irrevers
may
lead
deleteri
physiolog
condit
report
solubl
oligom
form
prefibrillar
state
produc
toxic
effect
thu
research
aim
delay
inhibit
fibril
process
insulin
prove
great
therapeut
valu
sever
report
aim
develop
therapeut
agent
inhibit
slow
amyloid
format
agent
rout
via
natur
sourc
synthet
pathway
gener
term
amyloid
inhibitor
idea
behind
antiamyloid
agent
inhibit
creation
amyloidogen
aggreg
andto
arrest
amyloid
construct
insulin
consist
two
polypeptid
chain
chain
residu
chain
b
residu
held
togeth
two
disulphid
bond
solut
state
insulin
contain
mixtur
differ
oligomer
speci
includ
hexam
tetram
dimer
monom
chain
consist
two
helic
section
wherea
chain
b
includ
region
extend
structur
helic
section
turn
termin
extend
bstrand
dissoci
insulin
oligom
monom
facilit
fibril
process
exist
conform
intermedi
serv
precursor
format
activ
nuclei
ultim
culmin
fibril
also
crucial
recent
work
laboratori
shown
trifluoroethanol
small
molecul
could
delay
fibril
insulin
interf
oligom
monom
dissoci
step
base
find
appear
logic
target
step
order
prevent
slow
fibril
process
peptid
consist
natur
amino
acid
consid
advantag
devoid
mani
drawback
thu
prefer
therapeut
present
studi
report
nineresidu
peptid
nivnvslvk
delay
fibril
process
insulin
even
substoichiometr
ratio
adopt
middl
sar
corona
viru
eprotein
primari
sequenc
initi
chosen
serendipit
gener
polypeptid
fragment
properti
selfrecognit
import
design
peptid
base
antiamyloidogen
agent
factor
like
peptid
length
select
respect
lor
danalogu
peptid
crucial
accord
mani
group
peptid
constitut
hydrophob
residu
known
execut
inhibit
oligomer
sever
biolog
import
protein
betasheet
breakerhydrophob
residu
like
ile
val
leu
present
studi
help
us
understand
probabl
mechan
action
delay
fibril
process
interfer
nucleat
phase
insulin
decreas
toxic
overal
process
report
show
differ
peptid
involv
delay
andor
inhibit
fibril
process
protein
without
give
signific
experiment
evid
emphasi
caus
phenomena
experiment
evid
bind
insulin
molecul
deriv
help
fluoresc
anisotropi
experi
molecular
interact
peptid
insulin
monitor
mean
nuclear
magnet
reson
nmr
spectroscopi
model
use
molecular
dynam
simul
valid
use
satur
transfer
differ
std
nmr
experi
studi
help
us
understand
interact
peptid
insulin
underli
mechan
delay
fibril
process
gener
strategi
prevent
insulin
fibril
one
earli
strategi
increas
stabil
insulin
suitabl
formul
longterm
storag
sinc
fibril
proce
via
dissoci
insulin
oligom
monom
strategi
prevent
insulin
fibril
also
includ
among
thing
promot
selfassoci
prevent
dissoci
monom
rational
behind
use
metal
ion
like
zn
ca
stabil
hexamer
structur
anoth
approach
stabil
insulin
promot
nativ
hydrophob
interact
andor
block
unwant
interact
polyhydroxi
compound
carbohydr
glycerol
prohibit
water
penetr
hydrophob
core
promot
nativ
hydrophob
interact
amphiphil
block
copolym
polyhydroxi
compound
cyclodextrin
lecithin
reduc
unwant
hydrophob
interact
engag
expos
hydrophob
group
thu
act
amyloid
inhibitor
recent
studi
explor
small
molecul
benzofuranon
deriv
quercetin
interf
dissoci
oligomer
insulin
monom
also
destabil
preform
insulin
fibril
recent
studi
laboratori
also
show
trifluoroethanol
tfe
bind
insulin
trimer
prevent
appear
solubl
oligom
believ
toxic
product
fibril
use
small
peptid
delay
insulin
fibril
also
report
recent
although
molecular
detail
interact
peptid
insulin
remain
elus
chosen
residu
peptid
also
slow
insulin
fibril
process
made
detail
spectroscop
character
fibril
process
insulin
function
time
also
attempt
get
molecular
detail
interact
peptid
insulin
understand
mechan
delay
fibril
format
thioflavin
tht
dye
preferenti
bind
amyloidlik
fibril
therebi
caus
substanti
enhanc
fluoresc
emiss
intens
time
cours
insulin
fibril
presenc
absenc
monitor
use
tht
fluoresc
figur
fluoresc
measur
carri
hr
usual
tht
fluoresc
remain
neglig
consider
period
time
lag
time
follow
sharp
increas
eventu
level
lag
time
insulin
fibril
min
delay
fibril
process
insulin
concentr
depend
manner
even
mm
concentr
molar
ratio
insulin
show
delay
effect
fibril
process
mm
concentr
molar
ratio
lag
time
fibril
process
minut
lag
time
increas
concentr
increas
tabl
howev
lag
time
remain
unchang
point
concentr
figur
also
depict
differ
bind
tht
insulin
fibril
absenc
presenc
evid
differ
final
fluoresc
emiss
intens
valu
order
understand
stage
interfer
insulin
fibril
process
ad
incub
insulin
solut
min
studi
effect
kinet
fibril
monitor
tht
fluoresc
figur
found
maximum
lag
time
min
observ
ad
begin
incub
nevertheless
ad
min
incub
lag
time
decreas
min
becam
min
peptid
ad
min
incub
almost
ident
insulin
without
peptid
figur
min
addit
tht
intens
kinet
profil
becam
similar
insulin
alon
satur
intens
level
lower
fact
satur
intens
level
tht
fluoresc
affect
littl
ad
thu
maximum
protect
fibril
obtain
present
system
time
thermal
incub
impli
start
interf
initi
stage
nucleat
process
initi
stage
nucleat
absenc
seem
min
incub
addit
min
thu
affect
fibril
kinet
affect
textur
fibril
possibl
interact
post
nucleat
structur
intermedi
differ
bind
behavior
tht
insulin
attribut
chang
fibril
morpholog
insulin
absenc
well
presenc
figur
fact
confirm
electron
micrograph
imag
insulin
fibril
presenc
absenc
figur
tem
data
show
insulin
fibril
absenc
branch
presenc
less
associ
figur
nevertheless
appar
rate
constant
fibril
growth
phase
remain
almost
everi
case
indic
delay
associ
process
prefibrillar
nucleat
phase
kinet
affect
post
nucleat
process
lead
fibril
growth
although
impact
fibril
morpholog
chang
secondari
structur
protein
cross
bsheet
structur
hall
mark
fibril
format
investig
chang
secondari
structur
insulin
absenc
presenc
help
circular
dichroism
cd
spectroscopi
insulin
helic
protein
show
dual
minima
nm
nm
characterist
major
helic
protein
figur
far
uvcd
spectra
insulin
differ
time
point
incub
absenc
well
presenc
respect
increas
time
incub
neg
ellipt
valu
nm
nm
also
decreas
indic
increas
order
secondari
structur
insulin
order
quantit
analysi
chang
secondari
structur
insulin
fibril
process
deconvolut
far
uvcd
data
help
cdnn
softwar
min
incub
helix
content
insulin
decreas
littl
increas
bsheet
structur
wherea
secondari
structur
insulin
presenc
remain
almost
unchang
min
incub
min
incub
helix
content
insulin
presenc
decreas
impli
help
insulin
retain
secondari
structur
prolong
period
time
appear
insolubl
aggreg
make
difficult
continu
cd
measur
beyond
min
incub
insulin
alon
min
incub
insulin
presenc
nevertheless
welldefin
structur
even
presenc
insulin
figur
effect
secondari
structur
chang
insulin
fibril
ftir
studi
ftir
use
studi
secondari
structur
protein
decad
particularli
sensit
chang
bsheet
content
protein
helic
protein
insulin
characterist
peak
cm
amid
contour
convers
amyloid
like
fibril
peak
shift
cm
hallmark
cross
bsheet
structur
format
figur
show
ftir
spectra
insulin
measur
variou
interv
incub
plot
time
incub
figur
show
small
chang
ratio
spectral
shape
take
place
first
h
incub
transit
involv
signific
increas
ratio
observ
h
incub
persist
h
caus
steadi
increas
intens
cm
concomit
decreas
intens
cm
figur
chang
reflect
format
cross
b
sheet
structur
insulin
expens
helic
content
insulin
presenc
retain
secondari
structur
h
incub
figur
ratio
h
incub
show
much
lower
valu
compar
ratio
case
insulin
alon
h
incub
figur
observ
indic
slow
stepwis
chang
insulin
secondari
structur
process
fibril
amount
helic
content
left
bsheet
content
increas
format
matur
fibril
calcul
use
multi
curv
fit
program
origin
softwar
figur
curv
fit
analysi
show
insulin
presenc
absenc
similar
percentag
ahelix
bsheet
content
figur
although
delay
fibril
process
insulin
matur
fibril
insulin
bsheet
content
irrespect
presenc
associ
state
insulin
presenc
absenc
determin
size
exclus
chromatographi
use
tskgel
hplc
column
column
precalibr
use
size
exclus
marker
protein
bamylas
adh
bsa
carbon
anhydras
lysozym
ribonucleas
calibr
data
fit
nice
linear
equat
correl
coeffici
r
sinc
incub
insulin
sampl
fibril
experi
done
use
citrat
phosphat
buffer
ph
hplc
column
equilibr
buffer
experi
insulin
confirm
use
bsa
lysozym
protein
retain
globular
shape
retent
time
acid
ph
significantli
chang
ph
data
shown
aliquot
insulin
solut
differ
time
point
incub
centrifug
forc
remov
visibl
turbid
supernat
load
hplc
column
prior
incub
insulin
citrat
phosphat
buffer
show
retent
time
ml
figur
retent
time
correspond
trimer
structur
insulin
corrobor
well
earlier
find
banga
cowork
retent
time
insulin
remain
unchang
hr
concomit
decreas
absorb
valu
increas
incub
time
hr
shift
retent
time
insulin
min
correspond
monomer
insulin
hr
incub
fluoresc
emiss
intens
start
increas
figur
impli
activ
nucleu
insulin
fibril
form
hr
incub
size
exclus
chromatographi
data
show
build
block
activ
nucleu
monom
insulin
conclus
agreement
literatur
data
well
insulin
incub
molar
ratio
show
two
distinct
retent
time
one
min
anoth
one
min
first
peak
could
due
complex
latter
alon
figur
sinc
contain
tryptophan
residu
peak
appear
min
absorb
valu
taken
wavelength
nm
figur
also
confirm
peak
appear
min
alon
sinc
short
peptid
bind
insulin
signific
influenc
molecular
mass
retent
time
insulin
consequ
retent
time
complex
ident
insulin
alon
incub
time
proce
absorb
figur
effect
bind
secondari
structur
insulin
insulin
fibril
monitor
circular
dichroism
select
buffer
subtract
faruv
cd
spectra
insulin
b
insulin
presenc
spectra
select
time
point
subtract
insulin
spectra
c
far
uvcd
spectra
presenc
absenc
insulin
insulin
spectra
subtract
insulin
spectra
concentr
insulin
mm
insulin
measur
sampl
dilut
mm
valu
retent
time
point
decreas
indic
insolubl
part
insulin
contain
peptid
sinc
much
chang
retent
time
complex
hr
incub
understood
stabil
associ
trimer
state
insulin
dynam
light
scatter
experi
show
hydrodynam
radiu
insulin
presenc
absenc
nm
respect
correspond
trimer
state
insulin
figur
min
incub
insulin
associ
form
larg
oligom
nm
size
along
trimer
associ
state
figur
time
incub
increas
popul
nm
size
oligom
increas
retain
min
incub
though
intens
scatter
higher
oligom
trimer
associ
state
insulin
percentag
trimer
insulin
much
higher
oligom
observ
also
evid
size
exclus
chromatographi
data
min
incub
insulin
trimer
disintegr
form
insulin
monom
nm
figur
believ
build
block
activ
nucleu
fibril
process
insulin
presenc
show
hydrodynam
radii
nm
indic
trimer
associ
state
nm
increas
within
experiment
error
say
increment
due
bind
residu
peptid
howev
subtl
chang
conform
insulin
bound
reflect
due
increas
scat
intens
incub
time
increas
figur
insulin
presenc
retain
trimer
state
minut
incub
figur
howev
min
incub
insulin
start
form
visibl
precipit
render
dl
experi
unsuit
conduct
time
point
fluoresc
anisotropi
fa
use
techniqu
studi
bind
interact
fluoresc
label
ligand
protein
theoret
interact
ligand
protein
increas
rotat
diffus
ligand
decreas
result
increas
anisotropi
figur
concentr
insulin
increas
anisotropi
also
increas
rapidli
initi
part
curv
thu
begin
ad
protein
immedi
bound
increas
anisotropi
becam
smaller
final
reach
plateau
plateau
reflect
anisotropi
satur
insulin
complex
experi
carri
two
differ
temperatur
valid
bind
insulin
higher
temperatur
anisotropi
experi
show
plateau
beyond
insulin
concentr
mm
impli
almost
bind
insulin
wherea
anisotropi
experi
show
plateau
beyond
mm
concentr
insulin
impli
almost
bind
insulin
bind
curv
obtain
appar
k
valu
mm
mm
bind
insulin
respect
gibb
free
energi
chang
associ
process
found
kjmol
respect
observ
clearli
indic
rate
complex
format
increas
elev
temperatur
obtain
structur
insight
complex
transfer
noesi
experi
perform
figur
peptid
absenc
presenc
insulin
predominantli
character
intra
residu
sequenti
noe
backbon
proton
side
chain
proton
reson
figur
clearli
indic
peptid
highli
flexibl
solut
state
adopt
fold
conform
presenc
insulin
result
good
agreement
cd
data
context
insulin
figur
understand
local
insulin
employ
one
dimension
proton
std
nmr
power
specif
techniqu
identifi
epitop
ligand
close
proxim
receptor
briefli
select
satur
receptor
transfer
bound
ligand
via
spin
diffus
without
affect
ligand
signal
alon
therefor
differ
spectrum
reson
reson
obtain
distanc
inform
epitop
ligand
bound
macromolecul
excess
ligand
compar
receptor
use
std
experi
achiev
effect
magnet
transfer
receptor
ligand
bound
state
figur
strong
std
effect
observ
methyl
group
presenc
insulin
figur
std
effect
absenc
insulin
figur
although
difficult
pin
point
aliphat
hydrophob
amino
acid
residu
due
signific
overlap
methyl
group
signal
could
residu
close
interact
insulin
c
b
hs
show
moder
std
effect
figur
c
hs
close
proxim
water
signal
interestingli
c
h
show
weak
std
signal
figur
taken
togeth
std
data
qualit
suggest
close
associ
hydrophob
amino
acid
residu
insulin
figur
molecular
model
use
get
structur
insight
complex
figur
show
dock
model
found
close
proxim
within
molecular
patch
nter
helic
portion
chain
b
key
residu
insulin
found
involv
contact
phe
val
gln
leu
leu
contrast
residu
chain
name
leu
tyr
glu
show
proxim
residu
dock
model
good
agreement
std
nmr
result
methyl
group
hydrophob
groov
form
aliphat
residu
chain
chain
b
insulin
residu
close
suggest
format
salt
bridg
hydrogen
bond
model
also
suggest
interact
insulin
either
hydrogen
bond
salt
bridg
hydrogen
bond
tyr
insulin
probabl
fibril
site
insulin
insulin
complex
also
identifi
use
biolumin
softwar
figur
physic
behavior
peptid
macromolecul
insulin
ns
md
simul
access
root
mean
squar
deviat
rmsd
radiu
gyrat
rg
root
mean
squar
fluctuat
rmsf
princip
compon
analysi
pca
figur
show
allatom
rmsd
individu
chain
insulin
dynam
complex
seem
stabl
unalt
even
ns
nterminu
chain
b
enforc
wide
rang
dynam
dock
model
design
locat
bind
nter
helic
region
chain
fluctuat
chain
b
tune
regul
restrict
fibril
format
rmsd
plot
chain
found
unaffect
simul
cours
observ
regard
loss
secondari
structur
chain
insulin
correspond
stabil
whole
structur
rg
shown
figur
correl
nice
rmsd
data
point
minut
increas
rg
genuin
attribut
absenc
crystal
pack
microcanon
ensembl
simul
larg
increment
correl
interact
disulfid
bridg
insulin
found
well
conserv
low
ph
simul
indic
one
reason
stabil
regard
rm
deviat
gyrat
radiu
chain
result
discuss
rmsd
rg
plot
clearli
explain
help
rmsf
fluctuat
chain
b
figur
fluctuat
respect
ca
atom
chain
residu
small
except
tyr
found
contact
ly
observ
mean
fluctuat
attribut
cationp
type
interact
two
residu
rmsf
chain
b
show
major
fluctuat
correspond
ly
ala
residu
ntermin
region
pca
one
import
tool
describ
stochast
movement
macromolecular
system
conform
sampl
simul
analyz
term
linear
relationship
atom
motion
use
first
three
prime
eigenvector
correl
scatter
plot
link
motion
relat
fluctuat
total
fluctuat
system
directli
relat
biophys
properti
figur
show
project
first
three
princip
compon
scatter
datapoint
categor
color
code
give
approxim
path
follow
complex
simul
time
cours
scatter
point
correspond
ns
show
time
portion
simul
complex
adopt
mani
conform
chang
find
favor
interact
chain
b
interestingli
atom
fluctuat
seem
converg
next
phase
analysi
ns
almost
conserv
global
minima
phase
ns
pca
help
conclud
structur
conform
obtain
beyond
ns
close
stabl
conform
low
ph
condit
remd
simul
give
certain
insight
base
upon
temperatur
platform
replica
actual
mimic
amyloid
form
check
low
ph
temperatur
k
k
trajectori
found
stabl
chain
b
interestingli
replica
exchang
studi
confirm
conform
switch
base
temperatur
variat
cross
energi
barrier
reach
form
defin
amyloid
plaqu
reason
replica
show
disord
deviat
plot
figur
vitro
hemolysi
assay
evalu
hemoglobin
releas
plasma
indic
red
blood
cell
lysi
follow
exposur
drug
agent
consider
accur
sensit
method
predict
hemolyt
activ
drug
studi
hemolyt
activ
peptid
show
less
hemolysi
variou
concentr
peptid
assay
final
concentr
mm
figur
percentag
hemolysi
measur
respect
triton
x
sampl
taken
control
consid
exhibit
hemolysi
experi
conduct
three
biolog
replic
similar
result
obtain
case
cytotox
assay
peptid
cell
line
also
perform
analysi
effect
live
cell
post
treatment
signific
less
cytotox
observ
toward
cell
line
differ
concentr
test
go
final
concentr
mm
triton
x
use
control
exhibit
viabil
cytotox
measur
calcul
percentag
viabl
cell
concentr
peptid
rel
control
sampl
without
peptid
consid
viabil
experi
repeat
replic
yield
similar
result
data
clearli
indic
peptid
nontox
lead
compound
peptid
sequenc
pave
way
develop
new
gener
antidiabet
drug
protein
insulin
pure
peptid
studi
project
purchas
sigma
st
loui
mo
gl
biochem
shanghai
china
respect
molecular
weight
peptid
confirm
esi
mass
spectrometri
human
blood
healthi
volunt
collect
use
approv
protocol
human
ethic
committe
bose
institut
kolkata
blood
drawn
experienc
clinic
technician
obtain
written
consent
volunt
hemolyt
assay
perform
prior
approv
protocol
said
committe
bovin
insulin
dissolv
mm
citrat
phosphat
buffer
ph
concentr
sampl
solut
determin
measur
absorb
nm
use
extinct
coeffici
insulin
mgml
cm
buffer
solut
degass
min
vigor
stir
filter
mm
disk
membran
immedi
use
degass
process
done
object
avoid
interfer
dust
micro
bubbl
experi
thioflavin
tht
dissolv
mili
q
water
concentr
determin
absorb
nm
use
molar
extinct
coeffici
cm
tht
fluoresc
sampl
monitor
mm
path
length
cuvett
incub
temperatur
hitachi
f
spectrofluoromet
excit
emiss
wavelength
set
measur
nm
nm
respect
insulin
concentr
cuvett
mgml
tht
mm
order
reproduc
result
tht
date
averag
three
measur
kinet
profil
analyz
curv
fit
boltzmann
equat
sigmoid
function
use
origin
softwar
faruv
cd
spectrum
record
wavelength
rang
ns
spectropolarimet
use
rectangular
cell
mm
path
length
insulin
solut
mgml
ph
incub
water
bath
aliquot
insulin
solut
taken
differ
time
incub
dilut
mgml
elimin
contribut
insulin
mix
system
also
separ
incub
aliquot
taken
differ
time
instant
incub
measur
cd
spectra
subtract
insulin
cd
spectra
respect
time
point
buffer
spectrum
also
subtract
spectrum
elimin
contribut
contribut
buffer
cd
result
express
term
mean
residu
ellipt
mre
ftir
measur
incub
insulin
solut
ml
taken
microcon
filter
devic
fit
cutoff
membran
dilut
ml
heavi
water
pd
sampl
centrifug
min
bring
volum
ml
dilut
ml
centrifug
deuterium
exchang
process
repeat
time
final
exchang
insulin
solutionsuspens
ml
place
two
caf
window
separ
mm
thick
teflon
spacer
ftir
scan
collect
rang
cm
resolut
cm
use
spectrum
ftir
spectromet
perkin
elmer
spectrum
pd
collect
subtract
sampl
spectrum
fourier
selfdeconvolut
use
resolv
overlap
band
ftir
spectrum
curv
fit
origin
amid
contour
perform
use
microc
origin
multi
peak
fit
programm
assign
amid
band
done
accord
literatur
data
percentag
secondari
structur
comput
fraction
area
correspond
peak
divid
sum
area
peak
amid
band
curv
fit
ftir
data
done
help
origin
softwar
use
multi
curv
fit
programm
imag
fibril
sampl
done
use
transmiss
electron
microscop
technai
sprit
biotwin
fei
acceler
voltag
kv
aliquot
ml
insulin
solut
place
copper
grid
coat
carbon
film
mesh
agar
scientif
stanst
uk
two
drop
contain
ml
uranyl
acet
agar
scientif
place
grid
excess
water
remov
care
filter
paper
grid
left
dri
air
stock
insulin
solut
filter
mm
disk
membran
dilut
final
concentr
mgml
experi
perform
preadjust
temperatur
time
baselin
correl
function
b
intercept
correl
function
q
nl
sin
scatter
vector
n
refract
index
solut
l
wavelength
laser
h
scatter
angl
hene
laser
nm
fix
detector
angl
h
use
timedepend
autocorrel
function
acquir
everi
ten
acquisit
run
data
averag
three
acquisit
size
exclus
chromatographi
perform
use
tskgel
column
tosoh
column
run
water
hplc
system
flow
rate
mlmin
dual
mode
detect
nm
column
equilibr
mm
citrat
phosphat
buffer
obtain
stabl
base
line
ml
mgml
insulin
solut
differ
incub
time
first
centrifug
supernat
solut
load
column
see
associ
state
insulin
presenc
absenc
marker
b
amylas
adh
bsa
carbon
anhydras
lysozym
ribonucleas
run
mm
phosphat
buffer
ph
howev
protein
retain
globular
shape
low
ph
condit
confirm
bsa
lysozym
bsa
lysozym
maintain
retent
volum
ph
data
shown
steadyst
anisotropi
record
hitachi
model
spectrofluoromet
equip
polar
accessori
excit
fitc
label
done
nm
fluoresc
anisotropi
valu
obtain
use
express
equat
vv
vh
vertic
horizont
polar
compon
probe
emiss
wavelength
nm
excit
vertic
polar
light
nm
g
sensit
factor
instrument
excit
emiss
slit
set
nm
fitc
tag
concentr
mm
wherea
insulin
concentr
vari
mm
curv
data
fit
use
one
site
bind
model
sigmaplot
softwar
accord
equat
b
max
maximum
valu
anisotropi
bind
process
k
dissoci
constant
insulin
complex
experi
carri
temperatur
nmr
spectra
record
bruker
avanc
iii
spectromet
equip
puls
field
gradient
data
acquisit
process
perform
topspin
softwar
suit
bruker
twodimension
tocsi
noesi
spectra
acquir
buffer
solut
contain
ph
peptid
concentr
mm
mix
time
tocsi
noesi
experi
set
ms
ms
respect
k
use
dss
sodium
salt
intern
chemic
shift
refer
seri
onedimension
proton
nmr
spectra
acquir
stepwis
addit
variou
concentr
insulin
stock
solut
mm
peptidesinsulin
complex
care
monitor
twodimension
transfer
noesi
trnoesi
experi
carri
peptidesinsulin
molar
ratio
k
three
differ
noesi
mix
time
ms
record
increment
k
data
point
spectral
width
normal
ppm
dimens
dummi
scan
scan
record
per
increment
zero
fill
data
matric
obtain
nmr
data
analysi
carri
use
program
sparki
goddard
g
kneller
univers
california
san
francisco
satur
transfer
differ
std
nmr
experi
insulin
dissolv
buffer
contain
lyophil
least
three
time
ph
adjust
std
nmr
experi
record
bruker
avanc
iii
spectromet
equip
temperatur
k
stdnmr
spectra
obtain
molar
ratio
insulin
k
scan
select
satur
insulin
reson
either
ppm
ppm
refer
spectra
use
seri
gaussianshap
puls
ms
ms
delay
puls
total
satur
time
subtract
perform
reson
spectra
phase
cycl
lead
differ
spectrum
contain
signal
aris
satur
transfer
noteworthi
mention
onedimension
proton
nmr
spectrum
insulin
show
broad
line
low
ph
ph
correspond
std
nmr
spectrum
reson
either
ppm
reson
ppm
show
success
satur
transfer
across
protein
data
shown
hand
free
peptid
show
std
effect
satur
frequenc
complex
data
process
perform
use
topspin
program
suit
start
structur
peptid
theoret
studi
built
use
tleap
modul
amber
short
minim
appli
clear
steric
clash
linear
start
structur
use
forc
field
coordin
process
desmond
md
system
structur
predict
simul
anneal
sa
protocol
appli
explicit
solvent
condit
obtain
structur
ensembl
variou
temperatur
scale
defin
sa
ps
frame
save
interv
ps
python
script
cluster
conform
llc
use
analysi
cluster
conform
done
base
atomposit
rootmeansquar
differ
rmsdiffer
coordin
insulin
heterodim
obtain
protein
data
bank
crystal
structur
process
protein
prepar
wizard
rectifi
problem
bond
order
overlap
atom
miss
atom
water
molecul
crystal
structur
kept
object
might
show
import
favor
interact
subsequ
theoret
studi
macromolecul
optim
iter
process
hbond
network
reorient
hydroxyl
group
amid
group
asn
gln
choos
appropri
state
orient
imidazol
ring
residu
protein
energi
minim
process
dock
dock
protocol
implement
patchdock
http
bioinfo
util
search
possibl
bind
orient
peptid
insulin
valid
dock
structur
confirm
use
stdnmr
two
interact
model
good
agreement
std
nmr
data
adopt
md
simul
studi
explicit
solvent
condit
simul
studi
carri
amber
forc
field
desmond
prepar
interact
complex
done
low
ph
condit
ph
thu
appropri
atom
proton
state
preserv
microcanon
system
forcefield
macomolecular
complex
solvat
boundari
edg
orthorhomb
boundari
condit
use
water
model
neutral
appropri
counter
ion
system
first
subject
first
energi
minim
step
steepest
descent
default
relax
protocol
present
desmond
md
system
understand
mechan
fibril
delay
insulin
get
structur
insight
interact
md
simul
perform
upto
ns
time
period
npt
ensembl
chosen
microcanon
system
biomolecular
simul
bar
pressur
constant
temperatur
k
control
use
relax
time
ps
electrostat
forc
comput
use
gaussian
split
ewald
method
respa
integr
use
fs
time
step
longrang
coulomb
interact
fs
time
step
remain
interact
mshake
algorithm
use
constraint
bond
length
hydrogen
realspac
part
electrostat
lennardjon
interact
cut
trajectori
save
interv
ps
analysi
princip
compon
analysi
pca
also
known
essenti
dynam
valuabl
tool
extract
largescal
correl
atom
motion
system
simul
trajectori
pca
provid
opportun
estim
domin
mode
structur
motion
thu
molecular
motion
judg
basi
either
instabl
stabil
data
point
pca
analysi
extract
simul
trajectori
use
gromac
program
trajectori
desmond
simul
convert
gromac
format
use
vmd
eigenvector
contribut
atom
correspond
collect
motion
extract
use
ganaeig
program
time
evolut
collect
coordin
protein
backbon
complex
simul
project
analyz
tri
explor
form
interact
complex
aid
scale
remd
valu
complex
period
ns
tune
system
temperatur
total
sixteen
replica
run
umbrella
sampl
simul
complex
temperatur
landscap
viz
k
solvat
dimens
ensembl
paramet
set
similar
explicit
md
simul
studi
probabl
prone
aggreg
predict
use
biolumin
suit
insulin
complex
model
simul
snapshot
acquir
appropri
proton
state
paramet
aggreg
site
predict
set
surfac
grid
space
probe
radiu
use
van
der
waal
surfac
order
creat
connolli
surfac
cutoff
radiu
find
hydrophob
neighbor
specifi
maximum
solventaccess
surfac
area
residu
regard
buri
fresh
human
blood
centrifug
min
cell
pellet
wash
thrice
resuspend
mm
pb
ph
obtain
final
concentr
erythrocyt
ml
equal
volum
erythrocyt
incub
vari
concentr
peptid
shake
hr
sampl
subject
centrifug
g
min
rbc
lysi
measur
differ
peptid
concentr
take
absorb
od
nm
complet
hemolysi
determin
use
triton
x
control
hemolyt
activ
peptid
calcul
percentag
use
follow
equat
p
optic
densiti
given
peptid
concentr
b
optic
densiti
buffer
optic
densiti
triton
x
cell
line
use
experi
human
fibro
sarcoma
cell
line
obtain
atcc
cell
maintain
dulbecco
modifi
eagl
medium
dmem
contain
penicillin
streptomycin
gentamycin
amphotericin
b
set
microwel
cultur
cell
frozen
stock
spread
mm
dish
dmem
incub
hr
co
rel
humid
cell
brought
suspens
trypsin
wash
phosphat
buffer
salin
resuspend
dmem
sampl
cell
suspens
ml
plate
well
plate
initi
confluenc
grown
till
reach
vari
concentr
peptid
ad
go
maximum
concentr
mm
incub
co
hr
cell
number
determin
stain
cell
addit
ml
methylen
blue
solut
methanol
well
follow
incub
room
temperatur
min
stain
aspir
plate
rins
millipor
water
twice
air
dri
plate
scan
nm
thermo
scientif
varioskan
flash
multimod
micro
plate
reader
averag
absorb
read
taken
differ
point
well
measur
percentag
viabil
cell
calcul
use
equat
treat
cellso
untreat
control
work
develop
nine
residu
biocompat
peptid
found
interrupt
insulin
fibril
process
use
thioflavin
fluoresc
observ
delay
fibril
process
insulin
dose
depend
manner
situ
addit
incub
insulin
solut
decreas
rate
fibril
process
slow
nucleat
process
even
submolar
ratio
insulin
fibril
form
presenc
morpholog
differ
form
absenc
found
stabil
nativelik
secondari
structur
insulin
thu
delay
dissoci
monom
precursor
fibril
nucleu
interfer
nucleat
process
fluoresc
anisotropi
measur
confirm
bind
insulin
micromolar
affin
free
energi
bind
decreas
increas
temperatur
indic
hydrophob
natur
interact
std
nmr
reveal
c
c
hs
c
b
hs
residu
close
proxim
insulin
md
simul
result
agreement
bind
behavior
insulin
complex
aggreg
site
found
leu
leu
per
dock
model
simul
trajectori
found
close
proxim
leu
tyr
glu
simul
result
indic
hydrophob
residu
prevent
solvent
perturb
influenc
insulin
fibril
probabl
fibril
site
insulin
also
identifi
use
biolumin
softwar
studi
may
provid
clue
develop
next
gener
peptid
organ
therapeut
tune
prevent
protein
fibril
